Referral and experience with genetic testing among women with early onset breast cancer.
作者： Karen L. Brown , Robin Hutchison , Randi E. Zinberg , Margaret M. McGovern
关键词:
摘要: The purpose of this study was to determine whether physicians refer women with early onset breast cancer for genetic testing BRCA1 and BRCA2, how respond being offered use the results. A web-based survey distributed 1221 cancer. included 158 questions divided into following sections: demographics, family history cancer, medical history, treatment experience testing. Of 551 diagnosed since 1993 who responded (45.1%), less than half (45%, n = 246) had ever discussed their physician and/or been referred see a counselor. Women (53%) Ashkenazi Jewish (81%) were more likely have referred. those testing, 60% undergone or interested in Overall 92 tested 19 (20.6%) these positive deleterious BRCA2 mutation. Fourteen (74%) te...
sci-hub.se 参考文章(26)
J Peto, D F Easton, D Ford, Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics. ,vol. 57, pp. 1457- 1462 ,(1995)
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau, C Isaacs, B Peshkin, S Buys, V Venne, P T Rowley, S Loader, K Offit, M Robson, H Hampel, D Brener, E P Winer, S Clark, B Weber, L C Strong, A Thomas, Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. Journal of Clinical Oncology. ,vol. 16, pp. 2417- 2425 ,(1998) , 10.1200/JCO.1998.16.7.2417
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
Elizabeth B. Claus, Joellen M. Schildkraut, W. Douglas Thompson, Neil J. Risch, The genetic attributable risk of breast and ovarian cancer Cancer. ,vol. 77, pp. 2318- 2324 ,(1996) , 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z
Amelia A. Langston, Kathleen E. Malone, Jennifer D. Thompson, Janet R. Daling, Elaine A. Ostrander, BRCA1 mutations in a population-based sample of young women with breast cancer. The New England Journal of Medicine. ,vol. 334, pp. 137- 142 ,(1996) , 10.1056/NEJM199601183340301
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley, Women's receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health. ,vol. 85, pp. 1133- 1135 ,(1995) , 10.2105/AJPH.85.8_PT_1.1133
Soo-Chin Lee, Barbara A. Bernhardt, Kathy J. Helzlsouer, Utilization of BRCA1/2 genetic testing in the clinical setting Cancer. ,vol. 94, pp. 1876- 1885 ,(2002) , 10.1002/CNCR.10420
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff, Olufunmilayo I Olopade, Barbara L Weber, None, Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations The New England Journal of Medicine. ,vol. 346, pp. 1616- 1622 ,(2002) , 10.1056/NEJMOA012158
Kathleen E. Malone, Janet R. Daling, Jennifer D. Thompson, Cecilia A. O'Brien, Leigh V. Francisco, Elaine A. Ostrander, BRCA1 Mutations and Breast Cancer in the General Population: Analyses in Women Before Age 35 Years and in Women Before Age 45 Years With First-Degree Family History JAMA. ,vol. 279, pp. 922- 929 ,(1998) , 10.1001/JAMA.279.12.922
Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson, Lauren Scheuer, Martee Hensley, Clifford A. Hudis, Nathan A. Ellis, Jeff Boyd, Patrick I. Borgen, Richard R. Barakat, Larry Norton, Mercedes Castiel, Khedoudja Nafa, Kenneth Offit, Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. The New England Journal of Medicine. ,vol. 346, pp. 1609- 1615 ,(2002) , 10.1056/NEJMOA020119